Can Renovascular Hypertension Caused by Renal Artery Stenosis Be Treated?
Renovascular hypertension—high blood pressure caused by narrowing of one or both renal arteries—is a treatable, though often underrecognized, form of secondary hypertension. The most common underlying
Renovascular hypertension—high blood pressure caused by narrowing of one or both renal arteries—is a treatable, though often underrecognized, form of secondary hypertension. The most common underlying cause is atherosclerosis, particularly in older adults and individuals with cardiovascular risk factors such as diabetes, smoking, or hyperlipidemia; fibromuscular dysplasia is another important etiology, especially in younger women.
Diagnosis requires a high index of suspicion and typically involves noninvasive imaging—such as duplex ultrasonography, magnetic resonance angiography (MRA), or computed tomographic angiography (CTA)—to confirm stenosis of ≥70% in the main renal artery or its major branches. Functional testing, including captopril renography or renal vein renin sampling, may help determine whether the stenosis is hemodynamically significant and likely to contribute to blood pressure elevation.
Treatment begins with optimal medical therapy: guideline-directed antihypertensive regimens—including ACE inhibitors or ARBs (with careful monitoring of renal function and potassium), calcium channel blockers, and diuretics—as well as aggressive management of modifiable risk factors like dyslipidemia, diabetes, and tobacco use. In select patients—particularly those with progressive renal dysfunction, recurrent flash pulmonary edema, or poorly controlled hypertension despite ≥3 antihypertensive agents—revascularization via percutaneous transluminal renal angioplasty with stenting (PTRAS) may be considered. However, large randomized trials such as CORAL and ASTRAL have shown no consistent benefit of stenting over medical therapy alone for most patients, underscoring that revascularization should be reserved for carefully selected cases evaluated by a multidisciplinary team.
Long-term outcomes depend on early detection, rigorous cardiovascular risk reduction, and individualized treatment planning. With appropriate management, many patients achieve meaningful blood pressure control and preservation of renal function—highlighting the importance of recognizing renovascular hypertension as a potentially reversible contributor to otherwise refractory hypertension.